-
-
-
-
-
-
-
H.C. Wainwright Reiterates Buy Rating on Microbot Medical (MBOT)
-
-
-
-
-
-
-
REMINDER: Microbot Medical to Highlight FDA 510(k) Clearance of the LIBERTY Endovascular Robotic System at the H.C. Wainwright Annual Investor Conference
-
-
-
-
-
-
-
Microbot Medical (MBOT) Announces 6.1M Share Offering at $2.13/sh
-
-
-
-
-
-
-
Microbot Medical (MBOT) Announces $7 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules
-
-
-
-
-
-
-
Microbot Medical Raises a Total of $7.6 Million in Gross Proceeds from Four Recent Registered Direct Offerings
-
-
-
-
-
-
-
Microbot Medical (MBOT) Announces $2.66 Million Registered Direct Offering of Common Stock
-
-
-
-
-
-
-
Microbot Medical (MBOT) Prices 1.02M Direct Offering at $4.89/sh
-
21,359 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

